Contact us:

This service is provided by the NIHR Office for Clinical Research Infrastructure.

+44 (0)20 3794 7380


Further information:  

Download the NIHR Medtech Capabilities brochure.

Download the Healthcare Technology Co-operatives: capabilities and expertise flyer. 

Download the NIHR Diagnostic Evidence Co-operatives flyer.

Blog: Rachel Forrest shares her experiences as Medical Technology Industry Manager, NIHR Clinical Research Network North East and North Cumbria

Case study: find out how our Study Support Service supports you to deliver medical device trials - The Light Mask

Work with our medical device, diagnostic and digital health experts 

The NIHR works in partnership with medical device and diagnostics companies to help them successfully translate ideas into innovative medical technologies for use in the NHS.

Our experts are based within NHS trusts and universities. They can support medical device and diagnostic companies across all stages of product development: from identifying unmet clinical needs to designing and running clinical studies.

Areas of expertise covered:

  • Patient care pathway analysis
  • Health economics
  • Clinical validation
  • Clinical evaluation
  • Device design
  • Regulatory advice
  • User testing and human factors
  • Public and patient involvement
  • Running clinical studies

Our Surgical technology evaluation page explains how we can help you to access clinicians and researchers in the NHS and research active surgeons to help you develop new surgical medical devices and technologies.

Our infrastructure

NIHR Medtech and In vitro diagnostics Co-operatives (MICs) build expertise and capacity in the NHS to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests. Leading NHS organisations act as centres of expertise, bringing together patients, clinicians, researchers, commissioners and industry. If you are interested in working with the NIHR MICs or would like more information, please contact the NIHR Office for Clinical Research Infrastructure: 

Who is this for?

These services are available for companies working in:

  • Medical device diagnostics / technology
  • In vitro diagnostics (IVD)
  • Imaging
  • Radiology
  • Non-life sciences
  • Software developers
  • Digital

Companies can access these resources at any stage in their product and clinical development process. Engaging with the NIHR at an early stage in your product development can provide real benefits, such as guidance on further development of the technology and early go/no go decisions.


By working together, our NIHR experts can help companies to generate the clinical evidence needed to support adoption and uptake by the NHS.

We can also offer advice on NIHR funding programmes that companies may be eligible to apply to for funding.

Development of a new screening tool for bowel cancer

Illustration of a person's abdomen showing the colon

E&B Devices approached the NIHR about developing a new ‘hands-free’ method of bowel cancer screening that had the potential to boost participation in screening programmes. The E&B Devices prototype detects extremely low amounts of blood in the stool directly in the toilet bowl, without the need to collect a sample. It measures luminescence which is emitted when two reagents, provided with the device, react with any haemoglobin present in the toilet bowl. The company was connected with the NIHR Colorectal Healthcare Technology Co-operative, which provided access to leading clinical experts in this field, including clinical biochemists, health economists and product design specialists. This provided invaluable advice about the technology, its clinical utility and potential cost-effectiveness – as well as areas for improvement.

Development of an electronic index to assess frailty

Stethoscope on a keyboard

NIHR CLAHRC Yorkshire and Humber has worked in collaboration with the clinical software development company TPP to develop an electronic Frailty Index (eFI) for informing care decisions. The eFI is designed to identify and severity grade frailty, allowing clinicians to identify the frailest people in their practice. The index uses routine primary care data contained in electronic health records and does not require additional clinical assessment. The eFI has been made available through SystmOne, the electronic patient record system used by over 2,000 General Practices. The resources of the NIHR CLAHRC have been pivotal at each stage of the development, validation and implementation of the eFI.